119 related articles for article (PubMed ID: 19267685)
41. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients.
Jaeger K; Osthaus A; Heine J; Ruschulte H; Kuhlmann C; Weissbrodt H; Ganser A; Karthaus M
Chemotherapy; 2001; 47(1):50-5. PubMed ID: 11125233
[TBL] [Abstract][Full Text] [Related]
43. Implantable venous access devices in children with hemophilia: a report of low infection rates.
Miller K; Buchanan GR; Zappa S; Cochran C; Laufenberg J; Medeiros D; Sanders J
J Pediatr; 1998 Jun; 132(6):934-8. PubMed ID: 9627581
[TBL] [Abstract][Full Text] [Related]
44. What really affects the incidence of central venous catheter-related infections for short-term catheterization?
Giles Y; Aksoy M; Tezelman S
Acta Chir Belg; 2002 Aug; 102(4):256-8. PubMed ID: 12244905
[TBL] [Abstract][Full Text] [Related]
45. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.
Koh DB; Gowardman JR; Rickard CM; Robertson IK; Brown A
Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598
[TBL] [Abstract][Full Text] [Related]
46. The influence of comorbidity on the risk of access-related bacteremia in chronic hemodialysis patients.
Mazonakis E; Stirling C; Booth KL; McClenahan J; Heron N; Geddes CC
Hemodial Int; 2009 Jan; 13(1):6-10. PubMed ID: 19210271
[TBL] [Abstract][Full Text] [Related]
47. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients.
Groeger JS; Lucas AB; Coit D; LaQuaglia M; Brown AE; Turnbull A; Exelby P
Ann Surg; 1993 Aug; 218(2):206-10. PubMed ID: 8343002
[TBL] [Abstract][Full Text] [Related]
48. [The risk factors associated with colonization and bacteremia in non-tunnelled central venous catheters].
Fortún Abete J; Asensio Vegas A; Pérez Molina JA; Navas Elorza E; Cobo Reinoso J; Guerrero Espejo A
Rev Clin Esp; 2000 Mar; 200(3):126-32. PubMed ID: 10804757
[TBL] [Abstract][Full Text] [Related]
49. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
50. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
[TBL] [Abstract][Full Text] [Related]
51. A Model to Predict Central-Line-Associated Bloodstream Infection Among Patients With Peripherally Inserted Central Catheters: The MPC Score.
Herc E; Patel P; Washer LL; Conlon A; Flanders SA; Chopra V
Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1155-1166. PubMed ID: 28807074
[TBL] [Abstract][Full Text] [Related]
52. Low risk of central venous thrombosis with nontunnelled central venous catheters.
Murphy PT; O'Connor N
Clin Lab Haematol; 2001 Jun; 23(3):187-8. PubMed ID: 11553060
[TBL] [Abstract][Full Text] [Related]
53. [Central venous catheter-related bacteraemia: prospective study in a Moroccan medical intensive care unit].
Aissaoui Y; Chouaib N; Chouikh C; Rafai M; Azendour H; Balkhi H; Haimeur C; Drissi Kamili N
Ann Fr Anesth Reanim; 2010 Dec; 29(12):897-901. PubMed ID: 21112733
[TBL] [Abstract][Full Text] [Related]
54. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia.
Raad I; Davis S; Khan A; Tarrand J; Elting L; Bodey GP
Infect Control Hosp Epidemiol; 1992 Apr; 13(4):215-21. PubMed ID: 1593102
[TBL] [Abstract][Full Text] [Related]
55. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.
Raad I; Hachem R; Hanna H; Bahna P; Chatzinikolaou I; Fang X; Jiang Y; Chemaly RF; Rolston K
Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):549-56. PubMed ID: 17582536
[TBL] [Abstract][Full Text] [Related]
56. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
57. Incidence of and factors associated with catheter-related bloodstream infection in patients with advanced solid tumors on home parenteral nutrition managed using a standardized catheter care protocol.
Vashi PG; Virginkar N; Popiel B; Edwin P; Gupta D
BMC Infect Dis; 2017 May; 17(1):372. PubMed ID: 28558699
[TBL] [Abstract][Full Text] [Related]
58. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients.
Rotstein C; Brock L; Roberts RS
Infect Control Hosp Epidemiol; 1995 Aug; 16(8):451-8. PubMed ID: 7594391
[TBL] [Abstract][Full Text] [Related]
59. Central venous catheter-related infections: a review.
Adal KA; Farr BM
Nutrition; 1996 Mar; 12(3):208-13. PubMed ID: 8798227
[TBL] [Abstract][Full Text] [Related]
60. Complications of indwelling venous access devices in patients with gynecologic malignancies.
Estes JM; Rocconi R; Straughn JM; Bhoola S; Leath CA; Alvarez RD; Kilgore LC; Huh WK
Gynecol Oncol; 2003 Dec; 91(3):591-5. PubMed ID: 14675682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
